Limbach Holdings, Inc. (LMB)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,330	964	500	109	93	98
Market Cap Growth	155.81%	92.73%	358.98%	17.54%	-5.11%	236.25%
Enterprise Value	1,345	959	482	134	108	122
Last Close Price	114.39	85.54	45.47	10.41	9.00	12.33
PE Ratio	39.19	31.23	24.11	16.03	13.81	16.83
Forward PE	31.30	29.91	25.91	12.90	7.63	15.13
PS Ratio	2.36	1.86	0.97	0.22	0.19	0.17
PB Ratio	7.80	6.28	4.14	1.14	1.06	1.82
P/TBV Ratio	13.33	12.17	6.29	1.59	1.56	2.72
P/FCF Ratio	56.11	32.96	9.08	3.17	-	2.55
P/OCF Ratio	46.72	26.22	8.72	3.08	-	2.46
PEG Ratio	3.13	2.49	2.16	1.08	0.56	1.26
EV/Sales Ratio	2.43	1.85	0.93	0.27	0.22	0.22
EV/EBITDA Ratio	22.40	17.66	12.27	5.96	5.24	5.25
EV/EBIT Ratio	29.43	22.62	15.53	9.37	7.37	7.14
EV/FCF Ratio	56.76	32.77	8.74	3.90	-	3.20
Debt / Equity Ratio	0.32	0.32	0.35	0.53	0.69	1.16
Debt / EBITDA Ratio	0.85	0.83	0.98	1.90	2.40	2.20
Debt / FCF Ratio	2.30	1.67	0.76	1.46	-	1.63
Asset Turnover	1.71	1.58	1.72	1.77	1.85	2.17
Quick Ratio	1.62	1.41	1.44	1.40	1.45	1.30
Current Ratio	1.69	1.46	1.50	1.42	1.49	1.33
Return on Equity (ROE)	23.26%	22.50%	19.18%	7.42%	9.49%	11.54%
Return on Assets (ROA)	8.83%	8.07%	6.47%	3.18%	3.44%	4.09%
Return on Capital (ROIC)	14.25%	14.51%	12.56%	6.07%	6.89%	9.39%
Return on Capital Employed (ROCE)	20.80%	21.10%	19.50%	10.60%	10.60%	15.30%
Earnings Yield	2.65%	3.20%	4.15%	6.24%	7.24%	5.94%
FCF Yield	1.78%	3.03%	11.01%	31.54%	-26.98%	39.22%
Buyback Yield / Dilution	0.31%	-1.82%	-10.64%	-4.35%	-26.86%	-5.26%

Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q